5 big analyst AI moves: Micron price targets hiked, cautious on SpaceX valuation
5 big analyst AI moves: Micron price targets hiked, cautious on SpaceX valuation
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
RAIN
USDS
LEO
ZEC
The token is down nearly 7% on the week with the altcoins falling harder. Bitcoin and ether are both ending the second quarter in the red, a back-to-back l...
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
5 big analyst AI moves: Micron price targets hiked, cautious on SpaceX valuation
A "race condition" after the system was reset prevented the sequencers from catching up, causing the second outage.
Bitcoin holds above $60,000 as Strategy's funding model faces growing scrutiny
The asset manager argues Bitcoin's fixed supply schedule does not undermine network security, even as miners face shrinking block rewards after each halvin...
Claiming benefits before full retirement age while keeping a job can trigger unexpected withholdings - but the money isn't lost forever.
Dogecoin is down 10.4% in 7 days and entering its statistically worst month âEUR" nine straight red Junes, 19 bearish signals, and key support at $0.07271....
Bitcoin held near $60,200 after a $10.63B Deribit options expiry cleared with max pain at $70,000. Here's what the post-settlement technicals say about BTC...
Bitcoin price retested $58K, Ethereum formed a double bottom, while MSTR plunged 10% as $3B in outflows rattled crypto markets. The post Crypto News, June...
Squeezed by stagnant wages, young Chinese are spending billions to buy "feelings."
Tesla (TSLA) has taken a lot of criticism for its self-driving ambitions. Regulators have cast doubt on the companyâEUR(TM)s safety assertions. Critics say...
Apogee Therapeutics is developing a promising atopic dermatitis drug.
The mixed messages on AI are another challenge when Gen Z already faces a tough job market.